Joseph E. Tomaszewski
American Society for Bone and Mineral Research(US)Zero to Three(US)John Wiley & Sons (United States)(US)National Cancer Institute(US)
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, PARP inhibition in cancer therapy, DNA Repair Mechanisms, Diverse Scientific and Economic Studies, Human auditory perception and evaluation
Most-Cited Works
- → Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies(2009)328 cited
- Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop.(1995)
- → Phase I Study of PARP Inhibitor ABT-888 in Combination with Topotecan in Adults with Refractory Solid Tumors and Lymphomas(2011)252 cited
- → Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer(1999)249 cited
- → Models for Evaluating Agents Intended for the Prophylaxis, Mitigation and Treatment of Radiation Injuries Report of an NCI Workshop, December 3–4, 2003(2004)242 cited
- → Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements(2010)238 cited